BioSig Technologies
WESTPORT, Connecticut, United States · Biotechnology, Finance, Financial Services
BSGM is a company focused on innovative financial solutions. They aim to expand their operations in various financial markets. The company is actively seeking to enhance its service offerings through strategic acquisitions.
Key facts
- Headquarters
- WESTPORT, Connecticut, United States
- Employees
- 11
- Industries
- Biotechnology, Finance, Financial Services
- Status
- Public (STEX)
- Website
- biosig.com
- Company page
Recent activity at BioSig Technologies
- : SEC 8-K (3.01): On October 7, 2026, Streamex Corp. received a notice from the Nasdaq Listing Qualifications staff indicating that the company's common stock failed to meet the minimum bid price requirement necessary for continued listing on The Nasdaq Capital Market. The non-compliance was based on the stock's closing bid price for 30 consecutive business days, from August 25, 2026, to October 6, 2026, falling below the required $1.00 per share. The company now has a compliance period of 180 days, expiring on April 5, 2027, to rectify this issue or face potential delisting. This situation could affect the company's ability to attract investment and maintain its operations effectively.
- : SEC 8-K (7.01):
- : SEC 8-K (5.02):
- : SEC 8-K (8.01): On May 27, 2026, Streamex Corp. announced the launch of a new 24/7 secondary liquidity infrastructure for trading tokenized securities, developed in collaboration with Orca, a prominent automated market maker on the Solana blockchain. This initiative aims to enhance liquidity and facilitate trading for holders of these digital assets. The announcement signifies Streamex's strategic commitment to expanding its offerings in the rapidly evolving landscape of digital finance. The press release detailing this launch is included as Exhibit 99.1 within the filing.
- : SEC 8-K (8.01): On May 26, 2026, Streamex Corp. appointed Kori Handy as Vice President of Product and Design. This strategic move is aimed at enhancing the company's product offerings and design capabilities. Kori Handy's experience in product management is expected to contribute to the growth and innovation initiatives within the company. The press release detailing this appointment was issued on the same day, underscoring its importance to the company's future direction.
- : SEC 8-K (5.02): On April 28, 2026, Streamex Corp. appointed Mr. Mitchell Young Williams, the Company’s Chief Investment Officer, as a non-independent director of the Board, with his term expiring at the 2026 annual meeting of stockholders. Additionally, an amended employment agreement was entered into with Mr. Williams, effective April 6, 2026, which sets his annual base salary at $350,000 and guarantees a minimum annual bonus of $100,000 for the 2026 fiscal year. The agreement includes provisions for 1,250,000 restricted stock units and an additional 1,000,000 special incentive award, subject to specific conditions, including a change in control or termination events affecting the current CEO. This strategic appointment aims to enhance the Board's capabilities and align Mr. Williams' incentives with shareholder interests.
- : SEC 8-K (7.01): On April 8, 2026, Streamex Corp. conducted a webcast to discuss its financial results for the year ended December 31, 2025, providing important corporate updates to its investors. The presentation from this event is available in the Investors section of the Company’s website and is included as Exhibit 99.1 in this filing. This communication aims to ensure compliance with Regulation FD, which governs the fair disclosure of information to investors. The webcast is vital for informing shareholders of the company's performance and strategic direction following the completion of its fiscal year.
- : SEC 8-K (1.01): On March 26, 2026, Henry McPhie, Chief Executive Officer, and Morgan Lekstrom, Executive Chairman of Streamex Corp. entered into Lock-Up Agreements. These agreements restrict the insiders from selling or transferring shares of the Company's common stock for one year, with specific conditions allowing for limited exceptions such as transfers to family members and gifts. This agreement aims to enhance shareholder confidence by limiting the potential for sudden share sales by key management. The Company clarified this development in a press release issued on March 27, 2026, refuting third-party claims about the expiration of prior lock-up agreements, thereby reinforcing its commitment to maintaining market stability.
- : SEC 8-K (5.02): On March 20, 2026, Streamex Corp. announced the resignation of Ferdinand Groenewald, the Chief Financial Officer, effective March 15, 2026. Mr. Groenewald's resignation did not arise from any disagreements regarding the company’s operations. As part of the Separation Agreement, he is entitled to cash severance payments of $112,500, pro-rata bonuses for 2025 and target bonuses for 2026, and reimbursement for COBRA coverage for up to 12 months. Additionally, Mr. Groenewald's outstanding restricted stock unit award was amended, reducing his RSUs from 500,000 to 301,500, with the adjusted RSUs and certain shares fully vesting immediately, thereby providing significant financial implications for both parties.
- : Streamex Corp. Appoints Christine Plummer as Chief Financial Officer
BioSig Technologies funding history
| Date | Round | Amount |
|---|---|---|
| Mar 2025 | Seed | $819K |
| Jun 2024 | Seed | $1.1M |
| Jun 2024 | Seed | $3.0M |
| Jan 2024 | Seed | $1.5M |
| Oct 2023 | Seed | $861K |
Leadership
- Anthony Amato, Executive Officer, Director
- Kenneth Londoner, Executive Officer, Director
- Donald Foley, Director
- Andrew Filler, Director
- Patrick Gallagher, Director
- Samuel Navarro, Director
- Jeffrey O'Donnell, Director
- David Weild, Director
- Jerome Zeldis, Director
- Martha Pease, Director
- Martha Pease, Director
- Jerome Zeldis, Director
Verified email and direct lines for BioSig Technologies’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Employee benefit plans
BioSig Technologies files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Aug 2027.
BioSig Technologies in the news
- Biosig Technologies Q2 Earnings Call Highlights - Yahoo Finance (Aug 17, 2026)
- Biosig Technologies Q1 Earnings Call Highlights - Yahoo Finance (May 20, 2026)
- BioSig Technologies, Inc. Announces New Appointments to its Now Fully Constituted Board of Directors, which is Comprised of 5 Board Members, 3 Independent - Investing News Network (May 03, 2024)
- Westport-based BioSig Technologies appeals delisting from Nasdaq - Hartford Business Journal (Jun 27, 2024)
- BioSig Technologies and Streamex: Pioneering Real-World Asset Tokenization in the U.S. Market - ETF.com (Jul 25, 2025)
- BioSig Technologies appoints new CEO - MassDevice (Apr 30, 2024)
- BioSig Technologies Stock: Now A Gold Tokenization Play (NASDAQ:BSGM) - Seeking Alpha (Aug 16, 2025)
- BioSig Enters into an LOI to Merge with Streamex Exchange Corp. Creating a Publicly Listed Real-World Asset Tokenization Company Led by Seasoned Industry Executives - BioSpace (May 06, 2025)
Companies similar to BioSig Technologies
- Wix · Finance, Financial Services, Fintech, Healthcare, Health Care, Software
- Nexi S.p.A · Biotechnology, Finance, Financial Services, Fintech, Health Care, Medical
- Ensysce Biosciences · Biotechnology, Finance, Financial Services, Fintech, Healthcare
- Eyenovia · Finance, Financial Services, Fintech, Healthcare, Health Care
- Evernorth · Biotechnology, Finance, Financial Services, Fintech, Health Care
About BioSig Technologies: questions and answers
What does BioSig Technologies do?
BSGM is a company focused on innovative financial solutions. They aim to expand their operations in various financial markets. The company is actively seeking to enhance its service offerings through strategic acquisitions.
Where is BioSig Technologies headquartered?
BioSig Technologies is headquartered in WESTPORT, Connecticut, United States.
How many employees does BioSig Technologies have?
BioSig Technologies has about 11 employees.
Has BioSig Technologies raised funding?
Yes. Fundz has recorded 5 funding events for BioSig Technologies. The most recent, Seed of $819K, was in Mar 2025.
What is the latest news on BioSig Technologies?
On Oct 07, 2026, SEC 8-K (3.01): On October 7, 2026, Streamex Corp. received a notice from the Nasdaq Listing Qualifications staff indicating that the company's common stock failed to meet the minimum bid price requirement necessary for continued listing on The Nasdaq Capital Market. The non-compliance was based on
Is BioSig Technologies a public company?
Yes. BioSig Technologies is publicly traded under the ticker STEX.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy